Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001246
Filing Date
2025-03-28
Accepted
2025-03-28 16:54:33
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2598371
2 ex4-1.htm EX-4.1 53348
3 ex19-1.htm EX-19.1 115606
4 ex23-1.htm EX-23.1 3560
5 ex31-1.htm EX-31.1 17785
6 ex31-2.htm EX-31.2 17889
7 ex32-1.htm EX-32.1 10589
8 ex32-2.htm EX-32.2 8874
  Complete submission text file 0001641172-25-001246.txt   11517043

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE cdt-20241231.xsd EX-101.SCH 85370
10 XBRL CALCULATION FILE cdt-20241231_cal.xml EX-101.CAL 92436
11 XBRL DEFINITION FILE cdt-20241231_def.xml EX-101.DEF 435470
12 XBRL LABEL FILE cdt-20241231_lab.xml EX-101.LAB 713151
13 XBRL PRESENTATION FILE cdt-20241231_pre.xml EX-101.PRE 574706
99 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1462371
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41245 | Film No.: 25787301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)